Bisphosphonate Treatment of Osteogenesis Imperfecta

Clinical trial NCT00063479 · COMPLETED

Trial details

NCT number: NCT00063479
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteogenesis Imperfecta

Start date: 2003-06-01
Primary completion: 2007-05-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.